SUBSTITUTED ALIPHANES, CYCLOPHANES, HETERAPHANES, HETEROPHANES, HETERO-HETERAPHANES AND METALLOCENES USEFUL FOR TREATING HCV INFECTIONS
申请人:Achillion Pharmaceuticals, Inc.
公开号:US20180055824A1
公开(公告)日:2018-03-01
The present disclosure provides substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes, of Formula I
D-M-D (Formula I)
useful as antiviral agents. In certain embodiments disclosed herein M is a group —P-A-P— where A is
Certain substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes disclosed herein are potent and/or selective inhibitors of viral replication, particularly Hepatitis C virus replication. Pharmaceutical compositions/and combinations containing one or more substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes and a pharmaceutically acceptable carrier are also provided by this disclosure. Methods for treating viral infections, including Hepatitis C viral infections are provided by the disclosure.
本公开提供了代替脂肪烷,环烷,杂环烷,杂环烷,杂-杂环烷和金属茂的化合物,其化学式为ID-M-D(化学式I),可用作抗病毒剂。在本文中披露的某些实施例中,M是一个组- P-A-P-,其中A是某些代替脂肪烷,环烷,杂环烷,杂环烷,杂-杂环烷和金属茂,是病毒复制的有效和/或选择性抑制剂,特别是丙型肝炎病毒复制的抑制剂。本公开还提供了含有一个或多个代替脂肪烷,环烷,杂环烷,杂环烷,杂-杂环烷和金属茂以及药学上可接受的载体的制药组合物/和组合物。本公开还提供了用于治疗病毒感染,包括丙型肝炎病毒感染的方法。